大参林: 大参林医药集团股份有限公司2024年年度股东大会决议公告

Meeting Overview - The shareholders' meeting of Dazhenglin Pharmaceutical Group Co., Ltd. was held on May 20, 2025, in Guangzhou [1] - The meeting was attended by shareholders representing 77.8557% of the total shares [1] - The meeting was conducted in accordance with the Company Law and the Articles of Association, with both on-site and online voting methods [1] Voting Results - All non-cumulative voting proposals were approved with high support from A-shareholders, including: - Proposal 1: 99.8008% in favor [1] - Proposal 2: 99.8015% in favor [1] - Proposal 3: 99.8009% in favor [1] - Proposal 4: 99.9882% in favor [1] - Proposal for the audit firm and internal control audit: 99.8592% in favor [1] Legal Compliance - The lawyers present confirmed that the meeting's procedures complied with relevant laws and regulations, ensuring the legality of the attendees and the voting process [3]